Peter Blom

This profile gathers the share dealings of Peter Blom in Karo Pharma AB. Between 31 March 2017 and 22 January 2019, the trades on record add up to 8 filings.

Both buying and selling appear: 4 purchases worth €59k, against 1 sale worth €122k. Netting one side against the other leaves €64k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2019, the count stands at no purchases and 1 sale.

In size, the median ticket on the buying side is €8,695. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

On 24 January 2019 came the latest disclosure, an open-market sale for €122k in Karo Pharma AB. The clock since the last published purchase (19 March 2018) now reads 3,156 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.